IMM

Immupharma Plc

ImmuPharma PLC Corporate Update

ImmuPharma PLC (LON: IMM), the specialist drug discovery and development company has today provided the following update on ongoing activities. Lupuzor™ Lupuzor™ is the Company’s late stage asset for Lupus, a

Immupharma Plc

My Worth Is Not Measured by My Work

I spent almost 20 years working in real estate in Florida. I loved the work, as it had me at times out measuring homes, meeting new people, and spending time

STRIX GROUP PLC ORD 1P
Strix Group plc CEO Mark Bartlett discusses the company's focus on safety controls, global reach, innovation, and growth opportunities for investors.
Firering Strategic MineralS PLC
Learn about Firering Strategic Minerals plc's operations and future plans from an exclusive interview with their Independent Non-Executive Director, Vassilios Carellas.
Pulsar Helium Inc
Discover insights into the helium sector as Stephane Foucard delves into the projects of junior companies, assessing key criteria for commercial viability.
Golden Matrix Group Inc
Golden Matrix Group Inc. CEO Brian Goodman discusses revenue growth, acquisitions, and global markets in an exclusive interview with DirectorsTalk.
XP Factory plc
XP Factory plc's CEO discusses financial highlights, growth targets, and a £10 million credit facility with Barclays in an exclusive interview with DirectorsTalk.